spacer
home > pmps > spring 2017 > breathing new life into asthma care
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Breathing New Life into Asthma Care

Smart inhalers represent a convergence of several market forces, technology and trends that are poised to change asthma care and improve outcomes. They are part of an overall smart device trend in mHealth focused at the multibillion dollar asthma industry. One of the biggest culprits of poor patient outcomes in asthma care is taking a reactive rather than proactive approach to treatment, and poor adherence of care plans among patients.

Why Smart Inhalers?

The technology around these devices can offer a number of benefits to both the patient and the healthcare provider, such as making it easier to remember to take prevention medicine and report symptoms, which can lead to improved disease self-management and adherence rates. Other benefits include their ability to collect actionable data and patients being able to identify their own patterns. Sixty-seven percent of patients do not take their inhalers correctly. With smart sensors built into these devices, the patient is told if they have shaken it correctly or not.

The sensors can also detect the quality of inhalation, which is very important when it comes to judging the effectiveness of the medication. Collection of key data, recognising patterns and potential aggravators to severe asthma attacks can help reduce costly readmissions and result in improved disease management as well as adherence rates. In the future, a convergence of trends and technologies will put smart inhalers and their accompanying data at the epicentre of managing asthma care. To this end, some companies

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
An engineer at heart and entrepreneur by trade, Ali Moiyed is founder and Chief Executive Officer of Aerobit Health. Living with asthma himself, he launched the digital healthcare company in July 2016.
spacer
Ali Moiyed
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

New research calls for pathology services to be better funded and prioritised


More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

 
Industry Events

7th American Drug Delivery & Formulation Summit

28-29 August 2017, The Westin Copley Place Boston Hotel

Innovative solutions to the greatest challenges in pharmaceutical development
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement